The 5-Year Risk Score: New AI tools can analyze your current “normal” tissue to identify hidden biomarkers of future risk.

Bruton tyrosine kinase inhibitors (BTKis) are a cornerstone of chronic lymphocytic leukemia (CLL) therapy, with newer second-generation agents developed to maintain efficacy while improving ...

Over the past four decades, rare disease drug development has evolved from a scientific aspiration into a central pillar of biopharmaceutical innovation. Regulatory reforms, scientific breakthroughs, ...

Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...

Several fruits, hardy vegetables, warming spices, and other foods contain anti-inflammatory compounds that help reduce inflammation for better overall health.

Median overall survival differed significantly by race: 36.8 months for Black patients versus 48.4 months for White patients ...

OVATION 3 is IMUNON’s pivotal Phase 3 study of IMMN-001, an IL-12 gene-mediated immunotherapy, in women with advanced stage epithelial ovarian cancer. The study is supported with unprecedented overall ...

Eli Lilly and Company (NYSE:LLY) Q4 2025 Earnings Call Transcript February 4, 2026 Eli Lilly and Company beats earnings ...

SOL-1 Phase 3 superiority trial results remain masked to dateSOL-1 data expected to be presented at the 49th Macula Society Annual Meeting Ocular ...

China’s National Medical Products Administration (NMPA) has granted regulatory approval for 2 next-generation ophthalmic ...

For people with depression who aren’t getting adequate relief from medication, new research suggests a high-fat, low-carb ...

Chamorro argued that the apparent difference in mortality likely reflects an "extremely low" event rate among control ...